| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| RMDResMed Inc. | 38.05B | 260.70 | 27.41 | 9.84% | 27.35% | 23.49% | 4.37% | 0.14 |
| ZJYLJin Medical International Ltd. | 22.54M | 0.14 | 6.13 | 18.57% | 10.94% | 16.93% | 0.41 | |
| FEMYFemasys Inc. | 38.2M | 0.64 | -0.76 | 51.97% | -9.61% | -434.6% | 3.23 | |
| NYXHNyxoah S.A. | 221.59M | 5.15 | -2.85 | 3.98% | -14.85% | -164.31% | 0.20 | |
| MLSSMilestone Scientific Inc. | 22.8M | 0.29 | -4.91 | -12.19% | -76.78% | -208.8% | 0.06 | |
| NVCRNovoCure Limited | 1.55B | 13.80 | -8.85 | 18.82% | -27.66% | -52.05% | 1.90 | |
| EKSOEkso Bionics Holdings, Inc. | 22.43M | 8.55 | -15.27 | -1.94% | -70.74% | -107.8% | 0.47 | |
| PLSEPulse Biosciences, Inc. | 955.52M | 14.10 | -15.33 | -868.99% | -80.62% | 0.08 |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Sales/Revenue | 929.06K | 1.04M | 1.18M | 1.21M | 1.07M | 1.63M |
| Revenue Growth % | - | 0.12% | 0.14% | 0.02% | -0.11% | 0.52% |
| Cost of Goods Sold | 223.68K | 306.53K | 370.38K | 441.94K | 380.07K | 544.9K |
| COGS % of Revenue | 0.24% | 0.3% | 0.31% | 0.37% | 0.35% | 0.33% |
| Gross Profit | 705.39K | 731.38K | 809.3K | 764.28K | 691.9K | 1.08M |
| Gross Margin % | 0.76% | 0.7% | 0.69% | 0.63% | 0.65% | 0.67% |
| Gross Profit Growth % | - | 0.04% | 0.11% | -0.06% | -0.09% | 0.57% |
| Operating Expenses | 12.34M | 7.66M | 9.15M | 12.36M | 15.2M | 18.87M |
| OpEx % of Revenue | 13.28% | 7.38% | 7.75% | 10.25% | 14.18% | 11.58% |
| Selling, General & Admin | 4.8M | 2.85M | 4.47M | 5.99M | 7.51M | 10.36M |
| SG&A % of Revenue | 5.17% | 2.75% | 3.79% | 4.97% | 7% | 6.36% |
| Research & Development | 6.91M | 4.13M | 4.08M | 5.81M | 7.21M | 8.22M |
| R&D % of Revenue | 7.44% | 3.98% | 3.46% | 4.82% | 6.72% | 5.04% |
| Other Operating Expenses | 625.78K | 679.65K | 591.07K | 561.23K | 483.48K | 297.32K |
| Operating Income | -11.64M | -6.93M | -8.34M | -11.6M | -14.51M | -17.79M |
| Operating Margin % | -12.53% | -6.68% | -7.07% | -9.62% | -13.53% | -10.92% |
| Operating Income Growth % | - | 0.4% | -0.2% | -0.39% | -0.25% | -0.23% |
| EBITDA | -10.54M | -5.83M | -7.37M | -10.71M | -13.6M | -16.91M |
| EBITDA Margin % | -11.35% | -5.62% | -6.25% | -8.88% | -12.69% | -10.38% |
| EBITDA Growth % | - | 0.45% | -0.26% | -0.45% | -0.27% | -0.24% |
| D&A (Non-Cash Add-back) | 1.09M | 1.1M | 964.29K | 889.14K | 907.99K | 872K |
| EBIT | -11.26M | -6.9M | -7.51M | -11.37M | -14.08M | -17.2M |
| Net Interest Income | 277.56K | 9.95K | -15.46K | 214.7K | 265.63K | -1.02M |
| Interest Income | 287.54K | 22.5K | 3.77K | 228.16K | 431.02K | 582.35K |
| Interest Expense | 9.97K | 12.55K | 19.23K | 13.46K | 165.39K | 1.6M |
| Other Income/Expense | 368.24K | 19.95K | 802.96K | 212.39K | 265.63K | -1.02M |
| Pretax Income | -11.27M | -6.91M | -7.53M | -11.39M | -14.24M | -18.81M |
| Pretax Margin % | -12.13% | -6.66% | -6.39% | -9.44% | -13.29% | -11.54% |
| Income Tax | 3.01K | 1.8K | 4K | 6.3K | 4.34K | 9.6K |
| Effective Tax Rate % | 1% | 1% | 1% | 1% | 1% | 1% |
| Net Income | -11.27M | -6.91M | -7.54M | -11.39M | -14.25M | -18.82M |
| Net Margin % | -12.13% | -6.66% | -6.39% | -9.45% | -13.29% | -11.55% |
| Net Income Growth % | - | 0.39% | -0.09% | -0.51% | -0.25% | -0.32% |
| Net Income (Continuing) | -11.27M | -6.91M | -7.54M | -11.39M | -14.25M | -18.82M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.96 | -0.59 | -0.64 | -0.97 | -0.93 | -0.84 |
| EPS Growth % | - | 0.39% | -0.08% | -0.52% | 0.04% | 0.1% |
| EPS (Basic) | -0.96 | -0.59 | -0.64 | -0.97 | -0.93 | -0.84 |
| Diluted Shares Outstanding | 11.76M | 11.76M | 11.8M | 11.8M | 15.38M | 22.27M |
| Basic Shares Outstanding | 11.76M | 11.76M | 11.8M | 11.8M | 15.38M | 22.27M |
| Dividend Payout Ratio | - | - | - | - | - | - |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Total Current Assets | 8.04M | 3.86M | 25.63M | 14.13M | 23.18M | 8.02M |
| Cash & Short-Term Investments | 7.41M | 3.32M | 24.78M | 12.96M | 21.72M | 3.45M |
| Cash Only | 6.42M | 3.32M | 24.78M | 12.96M | 21.72M | 3.45M |
| Short-Term Investments | 998.83K | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 83.55K | 125.79K | 84.26K | 77.47K | 98.91K | 488.37K |
| Days Sales Outstanding | 32.83 | 44.24 | 26.07 | 23.44 | 33.68 | 109.42 |
| Inventory | 172.5K | 131.38K | 208.27K | 436.72K | 667.12K | 3.05M |
| Days Inventory Outstanding | 281.48 | 156.44 | 205.24 | 360.69 | 640.67 | 2.04K |
| Other Current Assets | 370.02K | 284.12K | 555.85K | 655.36K | 695.88K | 1.04M |
| Total Non-Current Assets | 4.61M | 3.74M | 2.95M | 2.76M | 4.58M | 4.42M |
| Property, Plant & Equipment | 3.86M | 2.89M | 2.26M | 1.8M | 3.49M | 3.4M |
| Fixed Asset Turnover | 0.24x | 0.36x | 0.52x | 0.67x | 0.31x | 0.48x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 160.59K | 65.07K | 25.09K | 3.29K | 0 | 65.92K |
| Long-Term Investments | 0 | 0 | -20.38M | 0 | 0 | 0 |
| Other Non-Current Assets | 583.5K | 792.44K | 655.42K | 958.18K | 1.09M | 954.99K |
| Total Assets | 12.65M | 7.61M | 28.58M | 16.9M | 27.76M | 12.45M |
| Asset Turnover | 0.07x | 0.14x | 0.04x | 0.07x | 0.04x | 0.13x |
| Asset Growth % | - | -0.4% | 2.76% | -0.41% | 0.64% | -0.55% |
| Total Current Liabilities | 1.29M | 2.89M | 1.69M | 1.53M | 3.05M | 8.58M |
| Accounts Payable | 481.1K | 674.33K | 445.52K | 510.76K | 1.14M | 1.42M |
| Days Payables Outstanding | 785.06 | 802.95 | 439.05 | 421.84 | 1.09K | 950.54 |
| Short-Term Debt | 0 | 630.01K | 181.12K | 141.3K | 0 | 5.41M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 32.9K | 54.98K | 416.73K | 1.15M | 88.58K |
| Current Ratio | 6.25x | 1.34x | 15.15x | 9.25x | 7.59x | 0.93x |
| Quick Ratio | 6.12x | 1.29x | 15.02x | 8.96x | 7.37x | 0.58x |
| Cash Conversion Cycle | -470.75 | -602.28 | -207.73 | -37.7 | -418.37 | 1.2K |
| Total Non-Current Liabilities | 56.73M | 1.19M | 552.21K | 125.24K | 6.35M | 1.56M |
| Long-Term Debt | 0 | 182.49K | 0 | 0 | 4.26M | 0 |
| Capital Lease Obligations | 1.24M | 809.09K | 402.42K | 28.58K | 2.04M | 1.52M |
| Deferred Tax Liabilities | 0 | 0 | 20.38M | 0 | 0 | 0 |
| Other Non-Current Liabilities | 55.49M | 197.87K | 149.79K | 96.66K | 54.94K | 39.61K |
| Total Liabilities | 58.02M | 4.08M | 2.24M | 1.65M | 9.4M | 10.14M |
| Total Debt | 1.71M | 2.06M | 990.21K | 543.72K | 6.7M | 7.44M |
| Net Debt | -4.7M | -1.27M | -23.79M | -12.42M | -15.02M | 3.99M |
| Debt / Equity | - | 0.58x | 0.04x | 0.04x | 0.37x | 3.23x |
| Debt / EBITDA | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - |
| Interest Coverage | -1166.99x | -552.31x | -433.62x | -861.58x | -87.72x | -11.09x |
| Total Equity | -45.37M | 3.53M | 26.33M | 15.24M | 18.35M | 2.3M |
| Equity Growth % | - | 1.08% | 6.46% | -0.42% | 0.2% | -0.87% |
| Book Value per Share | -3.86 | 0.30 | 2.23 | 1.29 | 1.19 | 0.10 |
| Total Shareholders' Equity | -45.37M | 3.53M | 26.33M | 15.24M | 18.35M | 2.3M |
| Common Stock | 1.06K | 1.11K | 11.92K | 11.99K | 21.77K | 23.47K |
| Retained Earnings | -68.29M | -75.2M | -82.74M | -94.13M | -108.38M | -127.2M |
| Treasury Stock | -60K | -60K | -60K | -60K | -60K | -60K |
| Accumulated OCI | 20 | 702.49K | 702.49K | 567.97K | 2.79M | 1.86M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Cash from Operations | -11.01M | -4.93M | -7.93M | -10.73M | -11.28M | -19.44M |
| Operating CF Margin % | -11.85% | -4.75% | -6.72% | -8.9% | -10.52% | -11.94% |
| Operating CF Growth % | - | 0.55% | -0.61% | -0.35% | -0.05% | -0.72% |
| Net Income | -11.27M | -6.91M | -7.54M | -11.39M | -14.25M | -18.82M |
| Depreciation & Amortization | 1.09M | 1.1M | 964.29K | 889.14K | 907.99K | 872K |
| Stock-Based Compensation | 358.84K | 318.64K | 193.37K | 224.94K | 675.7K | 444.15K |
| Deferred Taxes | 0 | 0 | 3.64K | 0 | 0 | 0 |
| Other Non-Cash Items | -107.17K | 4.61K | -821.51K | 6.38K | 161.39K | 1.2M |
| Working Capital Changes | -1.08M | 557.96K | -732.72K | -458.27K | 1.22M | -3.14M |
| Change in Receivables | 3.26K | -42.24K | 41.53K | 6.79K | -21.44K | 8K |
| Change in Inventory | -34.73K | 35.32K | -77.43K | -232.55K | -236.28K | -2.38M |
| Change in Payables | -13.93K | 80.75K | -228.81K | 65.24K | 627.07K | 207.48K |
| Cash from Investing | 12.32M | 968.32K | -306.87K | -407.48K | -143.92K | -847.76K |
| Capital Expenditures | -696.5K | -8.35K | -306.87K | -407.48K | -143.92K | -761.71K |
| CapEx % of Revenue | 0.75% | 0.01% | 0.26% | 0.34% | 0.13% | 0.47% |
| Acquisitions | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - |
| Other Investing | -103.14K | -23.33K | 0 | 0 | 0 | -86.06K |
| Cash from Financing | -127.78K | 871.65K | 29.7M | -681.64K | 20.18M | 2.03M |
| Debt Issued (Net) | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - |
| Other Financing | -17.07K | -75K | -1.58M | -236.02K | 2.39M | 2.35K |
| Net Change in Cash | - | - | - | - | - | - |
| Free Cash Flow | -11.7M | -4.96M | -8.24M | -11.14M | -11.42M | -20.21M |
| FCF Margin % | -12.6% | -4.78% | -6.98% | -9.24% | -10.66% | -12.4% |
| FCF Growth % | - | 0.58% | -0.66% | -0.35% | -0.03% | -0.77% |
| FCF per Share | -0.99 | -0.42 | -0.70 | -0.94 | -0.74 | -0.91 |
| FCF Conversion (FCF/Net Income) | 0.98x | 0.71x | 1.05x | 0.94x | 0.79x | 1.03x |
| Interest Paid | 0 | 8.9K | 15.87K | 13.46K | 9.9K | 111K |
| Taxes Paid | 0 | 0 | 800 | 5.05K | 4.55K | 5.71K |
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | -196.01% | -50.49% | -54.81% | -84.82% | -182.18% |
| Return on Invested Capital (ROIC) | - | -229.94% | -260.47% | -324.4% | -353.19% | -276.97% |
| Gross Margin | 75.92% | 70.47% | 68.6% | 63.36% | 64.54% | 66.55% |
| Net Margin | -1213.26% | -666.24% | -638.97% | -944.62% | -1329.06% | -1155.03% |
| Debt / Equity | - | 0.58x | 0.04x | 0.04x | 0.37x | 3.23x |
| Interest Coverage | -1166.99x | -552.31x | -433.62x | -861.58x | -87.72x | -11.09x |
| FCF Conversion | 0.98x | 0.71x | 1.05x | 0.94x | 0.79x | 1.03x |
| Revenue Growth | - | 11.72% | 13.66% | 2.25% | -11.13% | 51.97% |
Femasys Inc. (FEMY) reported $2.1M in revenue for fiscal year 2024. This represents a 122% increase from $0.9M in 2019.
Femasys Inc. (FEMY) grew revenue by 52.0% over the past year. This is strong growth.
Femasys Inc. (FEMY) reported a net loss of $19.8M for fiscal year 2024.
Femasys Inc. (FEMY) has a return on equity (ROE) of -182.2%. Negative ROE indicates the company is unprofitable.
Femasys Inc. (FEMY) had negative free cash flow of $20.1M in fiscal year 2024, likely due to heavy capital investments.